Implementing LA-ARVs in Europe: Which Patient? Which Formulation?

European Meeting on HIV & Hepatitis 2022

Implementing LA-ARVs in Europe: Which Patient? Which Formulation?

European Meeting on HIV & Hepatitis 2022

HIV Transmission Clusters in Europe: A Perspective View of Late Presenters and Non-Late Presenters

European Meeting on HIV & Hepatitis 2022

Transmitted Drug Resistance to Integrase Based First-Line Treatment in Europe, 2018-2021

European Meeting on HIV & Hepatitis 2022

New Antiretroviral Compounds: What Are the Resistance Concerns?

European Meeting on HIV & Hepatitis 2022

New Antiretroviral Compounds: What Are the Resistance Concerns?

European Meeting on HIV & Hepatitis 2022

The Top 10 Important Observations Last Year

European Meeting on HIV & Hepatitis 2022

Country Experiences: Southern Europe / Italy

European Meeting on HIV & Hepatitis 2022

Country Experiences: Northern Europe / Sweden

European Meeting on HIV & Hepatitis 2022

Country Experiences: Eastern Europe / Czech Republic

European Meeting on HIV & Hepatitis 2022

Country Experiences: Western Europe / France

European Meeting on HIV & Hepatitis 2022

Levels and Durability of Humoral and T-Specific Responses After the Booster Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility

European Meeting on HIV & Hepatitis 2022

Impact of Sars-Cov-2 Omicron and Delta Sub-Lineage AY.4.2 Variant on Neutralization by Sera of Patients Treated With Different Licensed Monoclonal Antibodies

European Meeting on HIV & Hepatitis 2022

Circulation of SARS-CoV-2 Variants in Central Italy: Spike Variability Characterization by Deep-Sequencing (#2)

European Meeting on HIV & Hepatitis 2022

Characterization of SARS-CoV-2 Epidemic and Transmission Dynamics in Children Over the Four COVID-19 Waves

European Meeting on HIV & Hepatitis 2022

Special Lecture: Current Outbreaks of Concern

European Meeting on HIV & Hepatitis 2022

Early Clinical Phase - Antiviral Drugs

European Meeting on HIV & Hepatitis 2022

Early Clinical Phase - Monoclonal Antibodies

European Meeting on HIV & Hepatitis 2022

Impact of Variants on Clinical Presentation and Outcome in Severe COVID Disease

European Meeting on HIV & Hepatitis 2022

Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis - Helen Xu

APACC 2022

Intensified Screening for Mycobacterial Infections Using Gen-xpert Directly in Blood and Mycobacterial Culture in Hospitalized Patients with Advanced HIV Diseases in Vietnam - Dieu Nguyen

APACC 2022

Effects of HIV-Integrated TB interventions on Care Continuum Outcomes for Active TB: A Systematic Review and Meta-Analysis - Gifty Marley

APACC 2022

High Sexually Transmitted Infection Prevalence / Incidence Among New, Current, and Non-Users of Pre-Exposure Prophylaxis and HIV-Positive Men Who Have Sex with Men and Transgender Women Attending Key Population-Led Clinics in Thai - Narukjaporn Thammajaru

APACC 2022

Impact of COVID-19 Lockdown on Testing for and Diagnoses of Sexually Transmitted Infections in Bangkok, Thailand - Napon Pungpapong

APACC 2022